biotech · Melanoma · Psoriasis · PVCT
Provectus Biopharmaceuticals
PROVECTUS BIOPHARMACEUTICALS, INC.
Provectus Biopharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Knoxville, Tennessee 37932, US HQ
2004 Founded
7 Employees
Public company Type
PVCT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Knoxville, Tennessee 37932, US
- Founded
- 2004
- Employees
- 7
- Programs
- 12
- Drugs
- 5
- Patents
- 29
Provectus Biopharmaceuticals clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Provectus Biopharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Provectus Biopharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Provectus Biopharmaceuticals.
-
Rose bengal disodium — Phase 1
Clinical update -
Topical Rose Bengal, 0.005% — Phase 2
Clinical update -
PV-10 (rose bengal disodium, 10%) — Phase 1
Clinical update -
PV-10 — Phase 2
Clinical update -
PV-10 (10% rose bengal disodium) — Phase 2
Clinical update -
PH-10 (rose bengal disodium 0.001%) — Phase 2
Clinical update -
PH-10 (0.002% Rose Bengal) — Phase 2
Clinical update -
PH-10 (0.001% Rose Bengal) — Phase 2
Clinical update